International Journal of Molecular Sciences (Apr 2019)

Application of Acyzol in the Context of Zinc Deficiency and Perspectives

  • Gjumrakch Aliev,
  • Yi Li,
  • Vladimir N. Chubarev,
  • Svetlana A. Lebedeva,
  • Lidiya N. Parshina,
  • Boris A. Trofimov,
  • Susanna S. Sologova,
  • Alfiya Makhmutova,
  • Marco F. Avila-Rodriguez,
  • Sergey G. Klochkov,
  • Pavel A. Galenko-Yaroshevsky,
  • Vadim V. Tarasov

DOI
https://doi.org/10.3390/ijms20092104
Journal volume & issue
Vol. 20, no. 9
p. 2104

Abstract

Read online

Zinc is one of the most important essential trace elements. It is involved in more than 300 enzyme systems and is an indispensable participant in many biochemical processes. Zinc deficiency causes a number of disorders in the human body, the main ones being the delay of growth and puberty, immune disorders, and cognitive dysfunctions. There are over two billion people in the world suffering from zinc deficiency conditions. Acyzol, a zinc-containing medicine, developed as an antidote against carbon monoxide poisoning, demonstrates a wide range of pharmacological activities: Anti-inflammatory, reparative, detoxifying, immunomodulatory, bacteriostatic, hepatoprotective, adaptogenic, antioxidant, antihypoxic, and cardioprotective. The presence of zinc in the composition of Acyzol suggests the potential of the drug in the treatment and prevention of zinc deficiency conditions, such as Prasad’s disease, immune system pathology, alopecia, allergodermatoses, prostate dysfunction, psoriasis, stomatitis, periodontitis, and delayed mental and physical development in children. Currently, the efficiency of Acyzol in the cases of zinc deficiency is shown in a large number of experimental studies. So, Acyzol can be used as a highly effective drug for pharmacologic therapy of a wide range of diseases and conditions and it opens up new perspectives in the treatment and prevention of zinc deficiency conditions.

Keywords